JP Morgan Chase’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,900
Closed -$169K 7244
2025
Q1
$169K Buy
+3,900
New +$197K ﹤0.01% 5319
2023
Q4
Sell
-8,300
Closed -$566K 7618
2023
Q3
$566K Hold
8,300
﹤0.01% 4404
2023
Q2
$779K Hold
8,300
﹤0.01% 4234
2023
Q1
$563K Sell
8,300
-18,200
-69% -$1.17M ﹤0.01% 4422
2022
Q4
$1.31M Buy
+26,500
New +$1.08M ﹤0.01% 3874
2021
Q1
Sell
-98,500
Closed -$13.1M 6140
2020
Q4
$13.1M Sell
98,500
-1,500
-2% -$181K ﹤0.01% 1979
2020
Q3
$10.2M Buy
+100,000
New +$8.64M ﹤0.01% 2025
2020
Q1
Sell
-22,900
Closed -$2.12M 5404
2019
Q4
$2.12M Buy
+22,900
New +$2.01M ﹤0.01% 3343
2019
Q3
Sell
-27,000
Closed -$3.11M 5791
2019
Q2
$3.11M Buy
+27,000
New +$2.72M ﹤0.01% 3050
2018
Q4
Sell
-57,000
Closed -$4.5M 5746
2018
Q3
$4.5M Buy
+57,000
New +$3.72M ﹤0.01% 2824
2018
Q2
Sell
-27,000
Closed -$1.09M 5570
2018
Q1
$1.09M Sell
27,000
-13,000
-33% -$634K ﹤0.01% 3629
2017
Q4
$2.1M Buy
+40,000
New +$2.14M ﹤0.01% 3292

Other funds holding EXAS

JP Morgan Chase's EXAS Position: Q1 2026 in Review

JP Morgan Chase sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 674,621 shares — an estimated $68.5M sold.

JP Morgan Chase first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.41B in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • JP Morgan Chase reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 674,621 Exact Sciences shares in Q1 2026, an estimated $68.5M.
  • JP Morgan Chase first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • JP Morgan Chase's Exact Sciences position peaked at $1.41B in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.